<DOC>
	<DOC>NCT00245674</DOC>
	<brief_summary>During this study the efficacy and safety profile will be evaluated of the use of amisulpride in the form of a solution in schizophrenic patients with an acute episode. The main purpose of the study is to observe the anti-psychotic effect of amisulpride as a solution during the first days of an acute episode of schizophrenia.</brief_summary>
	<brief_title>SOLIACS: Solian Solution in the Acute Setting</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<criteria>schizophrenic inpatients with an acute episode aged between 18 and 65 years written informed consent pregnancy and breastfeeding breast cancer, prolactinoma, pheochromocytoma hypersensitivity to amisulpride or one of the other excipients contraindications when using amisulpride as per the SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>